Lentivirus-mediated gene transfer is a promising new approach for delivering genetic information to target cells to combat human disease, including diseases of the airway such as cystic fibrosis. However, a number of barriers, both physical and technical, must be overcome in order to implement this new technology safely and with high efficacy. This proposal, in three specific aims, outlines experiments designed to overcome physical barriers to successful transduction of well-differentiated human airway epithelia and also to improve the technical aspect of producing self-inactivating (SIN) lentiviral vectors by lentiviral packaging cells. The first specific aim describes novel approaches to vector pseudotyping in which the envelope proteins from human influenza A virus or human parainfluenza virus-3 are used to target lentiviral vectors to the apical membrane of polarized human epithelial cells. In the second specific aim, experiments are designed to characterize and overcome intracellular barriers that limit vector gene expression. The third specific aim describes the development of a double-SIN piggy-back vector that will improve the generation of packaging cell lines producing lentiviral vectors.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
2P01HL051818-11
Application #
6955750
Study Section
Heart, Lung, and Blood Initial Review Group (HLBP)
Project Start
2004-08-20
Project End
2009-06-30
Budget Start
2004-08-20
Budget End
2005-06-30
Support Year
11
Fiscal Year
2004
Total Cost
$245,130
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Type
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Johnson, Jarrod S; Gentzsch, Martina; Zhang, Liqun et al. (2011) AAV exploits subcellular stress associated with inflammation, endoplasmic reticulum expansion, and misfolded proteins in models of cystic fibrosis. PLoS Pathog 7:e1002053
Zhang, Liqun; Collins, Peter L; Lamb, Robert A et al. (2011) Comparison of differing cytopathic effects in human airway epithelium of parainfluenza virus 5 (W3A), parainfluenza virus type 3, and respiratory syncytial virus. Virology 421:67-77
Goudy, Kevin S; Johnson, Mark C; Garland, Alaina et al. (2011) Inducible adeno-associated virus-mediated IL-2 gene therapy prevents autoimmune diabetes. J Immunol 186:3779-86
Li, Wuping; Zhang, Liqun; Wu, Zhijian et al. (2011) AAV-6 mediated efficient transduction of mouse lower airways. Virology 417:327-33
Johnson, Jarrod S; Li, Chengwen; DiPrimio, Nina et al. (2010) Mutagenesis of adeno-associated virus type 2 capsid protein VP1 uncovers new roles for basic amino acids in trafficking and cell-specific transduction. J Virol 84:8888-902
Kwilas, Anna R; Yednak, Mark A; Zhang, Liqun et al. (2010) Respiratory syncytial virus engineered to express the cystic fibrosis transmembrane conductance regulator corrects the bioelectric phenotype of human cystic fibrosis airway epithelium in vitro. J Virol 84:7770-81
Mitchell, Angela M; Nicolson, Sarah C; Warischalk, Jayme K et al. (2010) AAV's anatomy: roadmap for optimizing vectors for translational success. Curr Gene Ther 10:319-340
Zhang, Liqun; Limberis, Maria P; Thompson, Catherine et al. (2010) ?-Fetoprotein gene delivery to the nasal epithelium of nonhuman primates by human parainfluenza viral vectors. Hum Gene Ther 21:1657-64
Li, C; Hirsch, M; Carter, P et al. (2009) A small regulatory element from chromosome 19 enhances liver-specific gene expression. Gene Ther 16:43-51
Limberis, Maria P; Vandenberghe, Luk H; Zhang, Liqun et al. (2009) Transduction efficiencies of novel AAV vectors in mouse airway epithelium in vivo and human ciliated airway epithelium in vitro. Mol Ther 17:294-301

Showing the most recent 10 out of 36 publications